| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $78.0M | +76.3% |
| SG&A Expense | $25.0M | +59.8% |
| Operating Income | -$103.2M | -72.0% |
| Pre-tax Income | -$95.9M | -75.3% |
| Income Tax | $9K | — |
| Net Income | -$95.9M | -75.3% |
| EPS (Basic) | -$0.48 | -45.5% |
| EPS (Diluted) | -$0.48 | -45.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $15.1M | -43.1% |
| Short-term Investments | $181.2M | +33.5% |
| Current Assets | $202.1M | +21.8% |
| Total Assets | $212.9M | +19.9% |
| Current Liabilities | $14.7M | +38.9% |
| Long-term Debt | $26.6M | +1.0% |
| Total Liabilities | $41.4M | +11.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$89.1M | -74.5% |
| Capital Expenditures | $25K | -91.6% |
| Investing Cash Flow | -$39.9M | +30.1% |
| Financing Cash Flow | $117.6M | +42.0% |
| Free Cash Flow | -$89.1M | -73.5% |
| Stockholders' Equity |
| $171.4M |
| +22.1% |